Embecta Corp.

Embecta Corp. closed its acquisition of Owen Mumford Holdings Ltd. for $200 million, including an upfront payment of about $135 million and up to $65 million in performance-based payments. Owen Mumford is a UK-based medical device manufacturer.

Embecta Corp. entered a definitive agreement to acquire Owen Mumford Holdings Limited, a UK-based medical device and drug-delivery technology company, for up to £150 million (£100 million upfront plus up to £50 million in performance-based payments). The transaction is expected to close in Embecta's fiscal third quarter of 2026.